Related Experiment Videos

The structure of amyloid-β dimers in Alzheimer's disease brain: a step forward for oligomers

Randall J Bateman^1,2,3, Kwasi G Mawuenyega¹, Norelle C Wildburger¹

¹Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.

Brain : a Journal of Neurology

|April 30, 2019

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Gantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease.

medRxiv : the preprint server for health sciences·2026

Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study.

The Lancet. Neurology·2026

Technology-natives and technology-adopters: Age differences in remote cognitive assessment in Alzheimer disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Spatiotemporal characterization of Alzheimer disease pathology in living human brain tissue.

Nature communications·2026

Remote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studies.

Alzheimer's & dementia (New York, N. Y.)·2026

Biomarker Variability Limits Individualized Amyloid Time Estimation in Alzheimer Disease.

bioRxiv : the preprint server for biology·2026

See all related articles